DUBLIN--(BUSINESS WIRE)--The "Drug Discovery Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Drug Discovery Services is estimated at US$48.6 Billion in 2023 and is projected to reach US$61.1 Billion by 2030, growing at a CAGR of 3.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The Medicinal Chemistry Services segment is on a significant growth trajectory, expected to reach US$31.6 billion by 2030 with a CAGR of 4%. The Biology Services segment is also anticipated to grow, albeit at a slower rate, with a 2.8% CAGR over the next seven years. The U.S. market is estimated at $12.9 billion in 2023, while China is forecasted to experience impressive growth with a 6.9% CAGR, reaching $14.1 billion by 2030. Other key regions, including Japan, Canada, Germany, and the Asia-Pacific, are also highlighted for their growth trends.
The report features comprehensive market data, providing independent analysis of annual sales and market forecasts in US$ million from 2023 to 2030. It offers in-depth regional analysis, delivering detailed insights into key markets such as the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. The report also includes company profiles of major players like Albany Molecular Research Inc., Charles River Laboratories International Inc., and Domainex, among others.
This report is essential for those seeking a detailed market analysis of the Global Drug Discovery Services Market, covering major geographic regions and market segments. It provides competitive insights into the market presence of major players across different geographies and discusses future trends and drivers shaping the industry's future. The report also offers actionable insights that can help identify new revenue opportunities and support strategic business decisions. Additionally, complimentary updates are provided for one year to keep readers informed of the latest market developments.
Key Questions Answered:
- How is the Global Drug Discovery Services Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 89 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $48.6 Billion |
| Forecasted Market Value (USD) by 2030 | $61.1 Billion |
| Compound Annual Growth Rate | 3.3% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Drug Discovery Services - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
FOCUS ON SELECT PLAYERS (Total 33 Featured)
- Albany Molecular Research Inc.
- Charles River Laboratories International Inc.
- Domainex
- Eurofins Scientific SE
- Evotec A.G.
- GenScript Biotech Corporation
- Jubilant Biosys Ltd.
- Laboratory Corporation of America Holdings
- Pharmaceutical Product Development LLC
- Piramal Enterprises Ltd.
- Selvita S.A.
- Thermo Fisher Scientific Inc.
- WuXi AppTec
For more information about this report visit https://www.researchandmarkets.com/r/usdw54
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
